A new-generation continuous glucose monitoring system: improved accuracy and reliability compared with a previous-generation system.

BACKGROUND Use of continuous glucose monitoring (CGM) systems can improve glycemic control, but widespread adoption of CGM utilization has been limited, in part because of real and perceived problems with accuracy and reliability. This study compared accuracy and performance metrics for a new-generation CGM system with those of a previous-generation device. SUBJECTS AND METHODS Subjects were enrolled in a 7-day, open-label, multicenter pivotal study. Sensor readings were compared with venous YSI measurements (blood glucose analyzer from YSI Inc., Yellow Springs, OH) every 15 min (±5 min) during in-clinic visits. The aggregate and individual sensor accuracy and reliability of a new CGM system, the Dexcom(®) (San Diego, CA) G4™ PLATINUM (DG4P), were compared with those of the previous CGM system, the Dexcom SEVEN(®) PLUS (DSP). RESULTS Both study design and subject characteristics were similar. The aggregate mean absolute relative difference (MARD) for DG4P was 13% compared with 16% for DSP (P<0.0001), and 82% of DG4P readings were within ± 20 mg/dL (for YSI ≤ 80 mg/dL) or 20% of YSI values (for YSI >80 mg/dL) compared with 76% for DSP (P<0.001). Ninety percent of the DG4P sensors had an individual MARD ≤ 20% compared with only 76% of DSP sensors (P=0.015). Half of DG4P sensors had a MARD less than 12.5% compared with 14% for the DSP sensors (P=0.028). The mean absolute difference for biochemical hypoglycemia (YSI <70 mg/dL) for DG4P was 11 mg/dL compared with 16 mg/dL for DSP (P<0.001). CONCLUSIONS The performance of DG4P was significantly improved compared with that of DSP, which may increase routine clinical use of CGM and improve patient outcomes.

[1]  R. Beck,et al.  Continuous glucose monitoring in children with type 1 diabetes. , 2007, The Journal of pediatrics.

[2]  M. Phillip,et al.  Effect of Continuous Glucose Monitoring on Hypoglycemia in Type 1 Diabetes , 2011, Diabetes Care.

[3]  Eric Renard,et al.  Incremental Value of Continuous Glucose Monitoring When Starting Pump Therapy in Patients With Poorly Controlled Type 1 Diabetes , 2009, Diabetes Care.

[4]  A. Bartelme,et al.  The Role of Reimbursement in the Adoption of Continuous Glucose Monitors , 2009, Journal of diabetes science and technology.

[5]  Kellee M Miller,et al.  The T1D Exchange clinic registry. , 2012, The Journal of clinical endocrinology and metabolism.

[6]  P. Cryer Hypoglycemia: still the limiting factor in the glycemic management of diabetes. , 2008, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[7]  D. Cox,et al.  Evaluating Clinical Accuracy of Systems for Self-Monitoring of Blood Glucose , 1987, Diabetes Care.

[8]  D. Klonoff,et al.  Continuous glucose monitoring: an Endocrine Society Clinical Practice Guideline. , 2011, The Journal of clinical endocrinology and metabolism.

[9]  T. Jones,et al.  Glycaemic impact of patient-led use of sensor-guided pump therapy in type 1 diabetes: a randomised controlled trial , 2009, Diabetologia.

[10]  Paul A Fournier,et al.  The effect of short-term use of the Guardian RT continuous glucose monitoring system on fear of hypoglycaemia in patients with type 1 diabetes mellitus. , 2012, Primary care diabetes.

[11]  Michael O'Grady,et al.  Continuous glucose monitoring and intensive treatment of type 1 diabetes. , 2008, The New England journal of medicine.

[12]  Bruce Buckingham,et al.  Response to nocturnal alarms using a real-time glucose sensor. , 2005, Diabetes technology & therapeutics.

[13]  Svetlana Ten,et al.  Real-Life Utilization of Real-Time Continuous Glucose Monitoring: The Complete Picture , 2011, Journal of diabetes science and technology.

[14]  R. Beck Effectiveness of Continuous Glucose Monitoring in a Clinical Care Environment , 2009, Diabetes Care.

[15]  R. Brazg,et al.  Accuracy of the 5-Day FreeStyle Navigator Continuous Glucose Monitoring System , 2007, Diabetes Care.

[16]  Howard Zisser,et al.  New features and performance of a next-generation SEVEN-day continuous glucose monitoring system with short lag time. , 2009, Diabetes technology & therapeutics.

[17]  M. Małecki,et al.  Efficacy and safety comparison of continuous glucose monitoring and self-monitoring of blood glucose in type 1 diabetes: systematic review and meta-analysis. , 2011, Polskie Archiwum Medycyny Wewnetrznej.

[18]  Howard Wolpert,et al.  Factors Predictive of Use and of Benefit From Continuous Glucose Monitoring in Type 1 Diabetes , 2009, Diabetes Care.

[19]  C. Chia,et al.  Glucose sensors: toward closed loop insulin delivery. , 2004, Endocrinology and metabolism clinics of North America.

[20]  Howard C. Zisser,et al.  Accuracy of the SEVEN® Continuous Glucose Monitoring System: Comparison with Frequently Sampled Venous Glucose Measurements , 2009, Journal of diabetes science and technology.

[21]  R. Mazze,et al.  Evaluating the accuracy, reliability, and clinical applicability of continuous glucose monitoring (CGM): Is CGM ready for real time? , 2009, Diabetes technology & therapeutics.

[22]  Christopher G. Parkin,et al.  Sensor-augmented insulin pump therapy: results of the first randomized treat-to-target study. , 2008, Diabetes technology & therapeutics.

[23]  M. Phillip,et al.  Use of Insulin Pump Therapy in the Pediatric Age-Group , 2007, Diabetes Care.

[24]  Stephanie J. Fonda,et al.  Short- and Long-Term Effects of Real-Time Continuous Glucose Monitoring in Patients With Type 2 Diabetes , 2011, Diabetes Care.

[25]  Howard Zisser,et al.  Improvement in glycemic excursions with a transcutaneous, real-time continuous glucose sensor: a randomized controlled trial. , 2006, Diabetes care.

[26]  H Peter Chase,et al.  A randomized multicenter trial comparing the GlucoWatch Biographer with standard glucose monitoring in children with type 1 diabetes. , 2005, Diabetes care.

[27]  J. Hans DeVries,et al.  Current Application of Continuous Glucose Monitoring in the Treatment of Diabetes , 2011, Diabetes Care.

[28]  R. Hovorka Continuous glucose monitoring and closed‐loop systems , 2006, Diabetic medicine : a journal of the British Diabetic Association.

[29]  I. Hirsch,et al.  Statement by the American Association of Clinical Endocrinologists Consensus Panel on continuous glucose monitoring. , 2010, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[30]  Roy Beck,et al.  Prolonged use of continuous glucose monitors in children with type 1 diabetes on continuous subcutaneous insulin infusion or intensive multiple‐daily injection therapy , 2009, Pediatric diabetes.

[31]  Howard C. Zisser,et al.  Reduction in hemoglobin A1C with real-time continuous glucose monitoring: results from a 12-week observational study. , 2007, Diabetes technology & therapeutics.

[32]  L. Jovanovic,et al.  Relationship of Fasting and Hourly Blood Glucose Levels to HbA1c Values , 2006, Diabetes Care.